Table 3.
Summary of the clinical and molecular data of published males with CDKL5 mutations (n=10)
| Reference | [13] (pt III.3)* | [20] (pt 1/8) | [20] (pt 2/8) | [20] | [21] (pt 3/8) | [22] | [23] | [25] (pt 1) | [25] (pt 6) | [25] (pt 9) |
|---|---|---|---|---|---|---|---|---|---|---|
| Ethnicity | nd | Italian | Italian | Italian | nd | nd | nd | nd | nd | nd |
| Age at assessment | 16y | 13y | 9y | 3y6m | 4y | 4y | 2y8m | 6m | 1y9m | 2y |
| Seizure onset | Neonatal | 3m | 8m | 2m | 2m | 15d | 2m | 1m | 2w | 3m |
| Seizure types | ISS, LG | ISS, MC, T, CPS | CPS, ISS, T, MC | T, ISS, CPS | ISS, GTC, T, MC | ISS, T, GTC, MC | ISS, T, PS | ISS | Spasms | ISS |
| Intractable epilepsy | + | + | + | + | + | + | + | + | + | + |
| CBR-CBL atrophy | nd | + | − | − | + | + | + | + | + | + |
| Abnormal movement s | + | + | + | − | − | + | − | nd | − | nd |
| Poor eye contact | − | + | + | − | + | + | − | nd | nd | nd |
| Tone | Spastic quadriparesis | Hypotonia | nd | Hypotonia | Hypotonia | Hypotonia | Hypotonia | No hypotonia | Hypotonia | Hypotonia |
| Earliest OFC-SD (age) | Normal (birth) | Normal (birth) | Normal (birth.) | nd | Normal (birth) | −1–2 (birth) | Normal (birth) | Normal (birth) | −1 (birth) | Normal (birth) |
| Last OFC- SD (age) | −2 (14y) | nd | nd | nd | nd | < 2 (2y) | 0 (2y8m) | nd | nd | nd |
| Postnatal MIC | + | nd | nd | nd | nd | + | − | − | − | − |
| Severe GDD | + | + | + | + | + | + | + | + | + | + |
| Other neurologic findings | Cortical blindness, hyperventilation | − | Pyramidal signs, ataxia, echolalia | − | − | breath- holding spells | − | nd | nd | nd |
| Other medical problems | GER, constipation, kyphoscoliosis | Mild facial DYSM | − | Mild facial DYSM | − | Mild facial DYSM | − | nd | nd | nd |
| Outcome | Deceased at 16y (aspiration pneumonia) | Alive | Alive | Alive | Alive | Alive | Alive | nd | nd | nd |
| Mutation/Deletion | c.183del T (exon 5) | c.872G> A (p.C291 Y) | c.863C> T (p.T288I) | c.872G> A (p.C291 Y) | c.191T> C (p.L64P) | c.1675C > T (p.R559 X) (47,XXY ) Balanced Xi (50%–50%) | c.99+5G > A (somatic mosaicism) | Exon1 deletion | c.533G> A (p.R178 Q) | c.1079de lT(p.L36 0Fs>367 X) |
| Type | Frameshift | Missense | Missense | Missense | Missense | Nonsense | Splicing; frameshift | Deletion | Missense | Frameshift |
| Inheritance | De novo | De novo | De novo | De novo | nd | nd | Somatic mosaicism | nd | De novo | nd |
| Family history | 2 affected sisters (twins) | Noncons anguinous parents; 1 healthy sib | Noncons anguinous parents; first child | Noncons anguinous parents; 2 SAB | Noncons anguinous parents; 1 healthy sib | Noncons anguinous parents; 1st child | Noncons anguinous parents | nd | nd | nd |
This patient’s two sisters (twins; 19 y) had the same mutation. III.1 had profound DD, decreased OFC (50–98% at birth; 2–50% at 19y), epileptic encephalopathy (seizure onset 9 wks; ISS, later had GTC, myoclonic, and absence seizures), generalized spasticity, scoliosis, constipation. III.2 had mild DD (IQ ~ 70), autistic features. She had no seizures, or tone abnormalities. Family history is also remarkable for two still-births and one miscarriage.